Anheuser-Busch InBev (NYSE: BUD) reports organic EBITDA growth of more than 2.0% year-on-year in Q3 FY2026 results (approx. October 29, 2026)
Hit
✦ AI-generated prediction
Published on 2. September 2026
·
Predicted for 29. October 2026
·
Based on: Historical Cycle
AB InBev delivered +3.3% organic EBITDA growth on +0.9% net revenue growth in Q3 2025 (TipRanks, October 30, 2025). Premiumization (Budweiser, Stella Artois, Corona internationally) and the BEES platform (~$1B quarterly GMV) protect margins. Headwinds: structural weakness in China, Brazilian competition. Supportive: US recovery, ex-Brazil LatAm, $6B buyback signals management confidence. Exceeding 2.0% organic EBITDA growth represents the lower end of the recent range. No direct Polymarket market available.
Data basis for this prediction
- AB InBev Q3 2025: organisches EBITDA +3,3 %, Nettoumsatz +0,9 %, BEES GMV ~1 Mrd. USD (TipRanks / Investing.com, 30. Oktober 2025)
- AB InBev 6-Mrd.-USD-Aktienrückkaufprogramm angekündigt Q4 2025 (Investing.com)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Hit
AB InBev meldete am 29. Oktober 2026 ein organisches EBITDA-Wachstum von +3,9 % (normalisiertes EBITDA: 5.957 Mio. USD) für Q3 2026 – deutlich über der Vorhersagehürde von >2,0 %. Treiber waren organisches Umsatzwachstum von +4,9 % (Revenue per hl +4,2 %), gestützt durch Premiumisierung und US-Erholung. Leicht dämpfend wirkten höhere Marketing-Investitionen und Rohstoffkosten (Margenkontraktion –34 Bp. auf 36,1 %) sowie anhaltende Schwäche in China. Quellen: SEC Form 6-K FY2026 (https://www.sec.gov/Archives/edgar/data/0001668717/000119312526437051/d159047dex991.htm), GuruFocus (https://www.gurufocus.com/news/9151085/), StockTitan (https://www.stocktitan.net/news/BUD/ab-in-bev-reports-third-quarter-2026-1elo9372djzp.html).
🍾 Beverages
✦ AI
Rémy Cointreau published its H1 FY2026/27 result on October 27, 2026: organic growth of +2.9 percent YoY for April–September 2026 — 90 basis points above this forecast's threshold. The company confirmed its FY2026/27 guidance ('gradual return to organic growth'). Q2 FY2026/27 (Jul–Sep): Cognac up 12 percent YoY. FY2025/26 full year: +0.2 percent organic ('in line with targets', Rémy IR, June 3, 2026). Achieving above 2.0 percent for the full year only requires H2 (Oct 2026–Mar 2027) to avoid a complete collapse — the 90-basis-point H1 buffer provides substantial safety margin. Risks: US demand weakness, Chinese Cognac tariffs, macro slowdown. Supporting: Rémy Martin premiumization strategy, confirmed guidance, strong Q2 momentum.
🍾 Beverages
✦ AI
After the record of 322 million bottles (2021), Champagne shipments are in structural decline: ~319 million in 2022, ~299 million in 2023 (CIVC). Continued luxury weakness in China (export volume –27% YoY H1 2026), rising input costs, and saturated key markets (USA, France, UK) point to further contraction. At –5 to –7% p.a. decline (2022–2025 trend), 2026 volume would be approximately 262–271 million bottles — well below the 280 million threshold. No prediction market signal available. Confirmed via CIVC annual report or Reuters by January 31, 2027.
🍾 Beverages
✦ AI
Analyst consensus for Q3 2026: EPS 0.2998 USD (~0.30 USD) with revenue of 2.49 billion USD (MarketBeat / TradingView, as of October 2026). Monster Beverage has beaten EPS consensus in a majority of recent quarters and continues to benefit from international market expansion in the energy drink segment. No active Polymarket or Kalshi market found for this event; beat probability estimated at ~65% based on historical beat rate and current consensus positioning.